ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: An unsatisfactory technique for clinical applications

Clinica Chimica Acta

Volumn 302, Issue 1-2, 2000, Pages 35-48

  Zambon, Carlo Federico ^a   Navaglia, Filippo ^a   Basso, Daniela ^a   Gallo, Nicoletta ^a   Greco, Eliana ^a   Piva, Maria Grazia ^a   Fogar, Paola ^a   Pasquali, Claudio ^a   Pedrazzoli, Sergio ^a   Plebani, Mario ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b Department of Laboratory Medicine ^*  (Italy)

Author keywords

Bile; K ras; ME PCR; Pancreatic cancer; Serum

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; BILE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; MALE; ONCOGENE K RAS; PANCREAS CANCER; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY; SERUM;

ADULT; AGED; AGED, 80 AND OVER; BILE; CODON; DNA; DNA MUTATIONAL ANALYSIS; ELECTROPHORESIS, AGAR GEL; FEMALE; GENES, RAS; HUMANS; MALE; MIDDLE AGED; MUTATION; PANCREATIC NEOPLASMS; POINT MUTATION; POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 0033764609     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00351-X     Document Type: Article

References (36)

1. Exocrine tumors of the pancreas
2. Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: State of the art
3. Genomic instability in colorectal cancer: Relationship to clinicopathological variables and family history
4. Cancers of the papilla of vater: Mutator phenotype is associated with good prognosis
5. Microsatellite instability and mutations of the Transforming Growth Factor b type II receptor gene in colorectal cancer
6. Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma
7. K(i)-ras oncogene activation in pre-invasive pancreatic cancer
8. K-ras oncogene activation in adenocarcinoma of the human pancreas
9. Mutated c-K(i)-ras in small pancreatic adenocarcinoma
10. K-ras mutations and allelic loss at 5q and 18q in the development of human pancreatic cancers
11. Recent discoveries in cancer genetics of exocrine pancreatic neoplasia
12. Molecular aspects of pancreatic cancer and future perspectives
13. Greater frequency of K-ras Val-12 mutation in colorectal cancer as detected with sensitive methods
14. Role of K-ras mutations in colorectal carcinoma
15. K-ras codon 12 mutation determines the polypoid growth of colorectal cancer
16. The molecular pathophysiology of myeloid leukaemias: ras revisited
17. Rapid and sensitive non-radioactive detection of mutant K-ras genes via 'enriched' PCR amplification
18. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma
19. Quantitative determination of K-ras point mutations in pancreatic juice for the diagnosis of pancreatic cancer using hybridization protection assay
20. K-ras mutations at codon 12 are rare events in chronic pancreatitis
21. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium
22. Detection of K-ras mutations in the stool(s) of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia
23. Detection of mutated c-K(i)-ras in the bile of patients with pancreatic cancer
24. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma
25. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures
26. Detection of mutations of p53 tumor suppressor gene in pancreatic juice and its application to the diagnosis of patients with pancreatic cancer: Comparison with K-ras mutation
27. High proportion of mutant K-ras gene in pancreatic juice of patients with pancreatic cystic lesions
28. A prospective study of K-ras mutations in the plasma of pancreatic cancer patients
29. Detection of ras gene mutations in peripheral blood of carcinoma patients using CD45 immunomagnetic separation and nested mutant allele specific amplification
30. Diagnosis of pancreatico-biliary malignancy: Detection of gene mutations in plasma and stool
31. K-ras mutations in DNA extracted from the plasma of patients with pancreatic carcinoma: Diagnostic utility and prognostic significance
32. Rapid and large scale method to detect K-ras gene mutations in tumor samples
33. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease
34. PCR and cancer diagnostics: Detection and characterization of single point mutations in oncogenes and antioncogenes
35. Soluble normal and muatted DNA sequences from single-copy genes in human blood
36. Clinical application of K-ras oncogene mutations in pancreatic carcinoma: Detection of micrometastases